These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38768417)

  • 61. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology.
    Galindo RJ; Aleppo G
    Diabetes Res Clin Pract; 2020 Dec; 170():108502. PubMed ID: 33065179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 64. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
    Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Imprecision nutrition? Duplicate meals result in unreliable individual glycemic responses measured by continuous glucose monitors across four dietary patterns in adults without diabetes.
    Hengist A; Ong JA; McNeel K; Guo J; Hall KD
    medRxiv; 2023 Dec; ():. PubMed ID: 37503002
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 68. Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes.
    Ajjan RA; Seidu S; Riveline JP
    Diabetes Ther; 2024 Aug; 15(8):1657-1672. PubMed ID: 38907936
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application.
    Fonda SJ; Salkind SJ; Walker MS; Chellappa M; Ehrhardt N; Vigersky RA
    Diabetes Care; 2013 Apr; 36(4):786-92. PubMed ID: 23172975
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
    Beck RW; Riddlesworth TD; Ruedy K; Ahmann A; Haller S; Kruger D; McGill JB; Polonsky W; Price D; Aronoff S; Aronson R; Toschi E; Kollman C; Bergenstal R;
    Ann Intern Med; 2017 Sep; 167(6):365-374. PubMed ID: 28828487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
    Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN).
    Chao C; Andrade SB; Bergford S; Calhoun P; Welsh JB; Walker TC;
    Endocrinol Diabetes Metab; 2023 May; 6(3):e414. PubMed ID: 36864014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study.
    Bisio A; Anderson S; Norlander L; O'Malley G; Robic J; Ogyaadu S; Hsu L; Levister C; Ekhlaspour L; Lam DW; Levy C; Buckingham B; Breton MD
    Diabetes Care; 2022 Jan; 45(1):186-193. PubMed ID: 34794973
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
    Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
    Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France.
    Roze S; Isitt JJ; Smith-Palmer J; Lynch P; Klinkenbijl B; Zammit G; Benhamou PY
    Diabetes Ther; 2021 Jan; 12(1):235-246. PubMed ID: 33165838
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
    Volčanšek Š; Lunder M; Janež A
    Diabetes Technol Ther; 2019 Oct; 21(10):566-574. PubMed ID: 31335199
    [No Abstract]   [Full Text] [Related]  

  • 80. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
    Garg SK; Voelmle MK; Beatson CR; Miller HA; Crew LB; Freson BJ; Hazenfield RM
    Diabetes Care; 2011 Mar; 34(3):574-9. PubMed ID: 21278138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.